{"id":245389,"date":"2026-09-15T09:42:19","date_gmt":"2026-09-15T04:12:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=245389"},"modified":"2026-09-15T09:42:19","modified_gmt":"2026-09-15T04:12:19","slug":"why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/","title":{"rendered":"SMS Pharmaceuticals Ltd. (SMSPHARMA) 52 Week High Streak: Second Straight Session Holds Focus"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/smspharma\/sms-pharmaceuticals-ltd-share-price-today\">SMS Pharmaceuticals Ltd. (SMSPHARMA)<\/a> share price reached a fresh 52-week high of Rs 482.45 today and later stood at Rs 446.3, down 3.88% from the previous close. Market cap was Rs 4,348.26 crore.<\/em><\/div>\n<div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/smspharma\/sms-pharmaceuticals-ltd-share-price-today\">SMS Pharmaceuticals Ltd.<\/a> has now set a fresh 52-week high for its second straight session, and the streak is up 6.48% across the two-session run. The latest peak was Rs 482.45, while the stock last traded at Rs 446.3. The latest Univest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.<\/p>\n<p style=\"margin-top:0!important;\">As of 15 September 2026 at 9:22 AM IST, the stock was below its previous close of Rs 464.3 after opening at Rs 470 and touching an intraday low of Rs 445.95. Turnover stood at Rs 2.1 crore and market capitalisation at Rs 4,348.26 crore. For readers, a repeated high matters differently from a one-day breakout because it shows the pattern has persisted across sessions, not just one intraday move.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#SMS_Pharmaceuticals_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"SMS Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis\">SMS Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#SMS_Pharmaceuticals_Ltd_52_Week_High_Streak_Consecutive_High_Analysis-2\" title=\"SMS Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis\">SMS Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#SMS_Pharmaceuticals_Ltd_SMSPHARMA_Fundamental_Analysis\" title=\"SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis\">SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_SMS_Pharmaceuticals_Ltd\" title=\"Why Investors Are Watching SMS Pharmaceuticals Ltd.\">Why Investors Are Watching SMS Pharmaceuticals Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#About_SMS_Pharmaceuticals_Ltd\" title=\"About SMS Pharmaceuticals Ltd.\">About SMS Pharmaceuticals Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Track_SMS_Pharmaceuticals_Ltd_on_Univest\" title=\"Track SMS Pharmaceuticals Ltd. on Univest\">Track SMS Pharmaceuticals Ltd. on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_does_SMS_Pharmaceuticals_Ltd_52_Week_High_Streak_mean\" title=\"What does SMS Pharmaceuticals Ltd. 52 Week High Streak mean?\">What does SMS Pharmaceuticals Ltd. 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_many_sessions_has_SMSPHARMA_made_a_fresh_52-week_high\" title=\"How many sessions has SMSPHARMA made a fresh 52-week high?\">How many sessions has SMSPHARMA made a fresh 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_is_the_latest_52-week_high_for_SMS_Pharmaceuticals_Ltd\" title=\"What is the latest 52-week high for SMS Pharmaceuticals Ltd.?\">What is the latest 52-week high for SMS Pharmaceuticals Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Is_a_company-specific_catalyst_confirmed_for_the_streak\" title=\"Is a company-specific catalyst confirmed for the streak?\">Is a company-specific catalyst confirmed for the streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_is_SMSPHARMA_valued_compared_with_its_industry\" title=\"How is SMSPHARMA valued compared with its industry?\">How is SMSPHARMA valued compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_do_the_profitability_ratios_show\" title=\"What do the profitability ratios show?\">What do the profitability ratios show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Why_is_the_stock_being_watched_now\" title=\"Why is the stock being watched now?\">Why is the stock being watched now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_should_investors_monitor_next\" title=\"What should investors monitor next?\">What should investors monitor next?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-sms-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Track_SMS_Pharmaceuticals_Ltd_SMSPHARMA_Share_Price_on_Univest\" title=\"Track SMS Pharmaceuticals Ltd. (SMSPHARMA) Share Price on Univest\">Track SMS Pharmaceuticals Ltd. (SMSPHARMA) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"SMS_Pharmaceuticals_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>SMS Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 446.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 464.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -18 (-3.88%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 470<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 482.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 445.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.1 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,348.26 crore<\/td>\n<\/tr>\n<\/table>\n<p>SMS Pharmaceuticals Ltd. (SMSPHARMA) traded at Rs 446.3 versus the previous close of Rs 464.3, a fall of 3.88%. The stock opened at Rs 470, reached a high of Rs 482.45 and touched a low of Rs 445.95.<\/p>\n<p>SMS Pharmaceuticals Ltd. share price today is trading lower than the previous close, with the stock at Rs 446.3 versus Rs 464.3 in the prior session. That reflects a decline of Rs 18, or 3.88%, from the previous close. The session opened at Rs 470, touched a high of Rs 482.45 and a low of Rs 445.95, which means the price is now nearer the day\u2019s lower end than the day\u2019s high.<\/p>\n<p>This move comes after the stock had already marked a fresh 52-week high, so the key point is not only the one-day change but the fact that SMS Pharmaceuticals Ltd. has continued to print a new one-year peak for a second straight session. Turnover was Rs 2.1 crore, while market capitalisation was Rs 4,348.26 crore. For investors tracking SMSPHARMA share price today, the immediate read is a stock that remains in the news today because of the streak rather than any single-session price print.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SMS_Pharmaceuticals_Ltd_52_Week_High_Streak_Consecutive_High_Analysis-2\"><\/span><strong>SMS Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SMS Pharmaceuticals Ltd. has now set a fresh 52-week high for a second straight session, and that is the central fact behind the current SMSPHARMA 52 Week High Streak. The cumulative gain across the streak is 6.48%, which gives a fuller picture than the latest quote alone. The latest peak of Rs 482.45 also matters because it extends the prior one-year high rather than merely matching it.<\/p>\n<p>Because the latest Univest data confirms the pattern but does not assign a catalyst, the repeated high should be read as a market price event first and a news event second. The stock\u2019s renewed one-year high also means the current SMS Pharmaceuticals Ltd. share price update remains part of the broader \u201cStocks Hitting 52 Week Highs\u201d and \u201cStocks At One Year High Today\u201d conversation. What stands out is the persistence of the move across sessions, not a one-off print.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The repeated highs show that SMS Pharmaceuticals Ltd. has sustained its position near the upper end of its recent price range across more than one session. The streak is now clearly established, and the current reading keeps SMSPHARMA in the category of stocks at one-year high today. That makes the move more notable than a single-day high because the market has continued to reprice the stock at new levels on successive sessions.<\/p>\n<p>At the same time, the available numbers do not establish why the stock has kept setting new highs. There is no confirmed company-specific trigger in the figures, so it is better to describe the pattern as confirmed and the reason as unconfirmed. For readers looking at SMSPHARMA stock performance, the practical takeaway is that a back-to-back 52-week high sequence often draws attention to the stock price, but the facts here only support the price pattern itself. The focus keyword SMS Pharmaceuticals Ltd. 52 Week High Streak therefore reflects the real event more accurately than a one-day breakout headline would.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SMS_Pharmaceuticals_Ltd_SMSPHARMA_Fundamental_Analysis\"><\/span><strong>SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,348.26 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">42.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.91%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.55%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 10.93<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 86.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.09%<\/td>\n<\/tr>\n<\/table>\n<p>SMS Pharmaceuticals Ltd. (SMSPHARMA) fundamental metrics show P\/E 42.46x, P\/B 5.39x, ROE 11.91%, ROCE 12.55%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>SMS Pharmaceuticals Ltd. has a market capitalisation of Rs 4348.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 42.46x, P\/B at 5.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.91% and ROCE of 12.55%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.93, book value per share of Rs 86.06, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 32.41x, median ROE of 11.61%, median ROCE of 13.43%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">42.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.19x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.34x to 693.7x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.91%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.55%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,348.26 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 692.38 crore<\/td>\n<\/tr>\n<\/table>\n<p>SMS Pharmaceuticals Ltd. (SMSPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P\/E ratio of 42.46x, which is above the benchmark median of 32.41x, a difference of +31.01%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROE of 11.91%, which is above the benchmark median of 11.61%, a difference of +2.58%. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROCE of 12.55%, which is below the benchmark median of 13.43%, a difference of -6.55%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/guficbio\/gufic-biosciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Gufic Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GUFICBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,254.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">57.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.56<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/rpglife\/rpg-life-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>RPG Life Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">RPGLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,456.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.99<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aartidrugs\/aarti-drugs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aarti Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AARTIDRUGS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,909.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/unichemlab\/unichem-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Unichem Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">UNICHEMLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,783.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,779.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.63<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.01<\/td>\n<\/tr>\n<\/table>\n<p>SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P\/E ratio of 42.46x compared with the displayed peer median of 38.7x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.91% compares with a peer median of 12.68% across the companies shown in the table. ROCE stood at 12.55% versus the displayed peer median of 13.11%, providing a capital-efficiency comparison. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a market capitalisation of Rs 4,348.26 crore. Among the 5 peers shown, 1 has a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_SMS_Pharmaceuticals_Ltd\"><\/span><strong>Why Investors Are Watching SMS Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>SMS Pharmaceuticals Ltd. has set a fresh 52-week high for a second straight session.<\/li>\n<li>The cumulative move across the streak is 6.48%.<\/li>\n<li>The latest 52-week high stood at Rs 482.45.<\/li>\n<li>Valuation remains a key talking point, with P\/E at 42.46 and P\/B at 5.39.<\/li>\n<li>The stock is being compared with other Pharmaceuticals &#038; Drugs names in the Healthcare sector.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_SMS_Pharmaceuticals_Ltd\"><\/span><strong>About SMS Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SMS Pharmaceuticals Ltd. is part of the Healthcare sector and the Pharmaceuticals &#038; Drugs industry, and it is listed on NSE and BSE under the symbol SMSPHARMA. The company\u2019s market capitalisation is Rs 4,348.26 crore, placing it within a competitive set of mid-sized listed pharmaceutical names by market value in the peer sample.<\/p>\n<p>For readers following SMS Pharmaceuticals Ltd. stock performance, the current focus is on how the repeated 52-week high streak fits with the company\u2019s valuation, profitability ratios and peer positioning. The latest prices and market-cap figures are the main reference points available for tracking the stock from here.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_SMS_Pharmaceuticals_Ltd_on_Univest\"><\/span><strong>Track SMS Pharmaceuticals Ltd. on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Track SMS Pharmaceuticals Ltd. on Univest to follow the latest SMSPHARMA share price, stock news and company updates. The stock page can help readers monitor the next market move after this second straight session of fresh 52-week highs, along with future valuation and sector comparisons.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_SMS_Pharmaceuticals_Ltd_52_Week_High_Streak_mean\"><\/span><strong>What does SMS Pharmaceuticals Ltd. 52 Week High Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means SMS Pharmaceuticals Ltd. has set a fresh 52-week high on consecutive sessions. In this case, the streak is for a second straight session, which makes the one-year high pattern more notable than a single-day breakout.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_SMSPHARMA_made_a_fresh_52-week_high\"><\/span><strong>How many sessions has SMSPHARMA made a fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SMS Pharmaceuticals Ltd. has made a fresh 52-week high for two consecutive sessions. The latest streak label is second straight session, and the cumulative move across that run is 6.48%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_52-week_high_for_SMS_Pharmaceuticals_Ltd\"><\/span><strong>What is the latest 52-week high for SMS Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest 52-week high for SMS Pharmaceuticals Ltd. is Rs 482.45. The stock touched that level during the current streak, which is why the move is being tracked as a repeated one-year high event.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_a_company-specific_catalyst_confirmed_for_the_streak\"><\/span><strong>Is a company-specific catalyst confirmed for the streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No company-specific catalyst is confirmed by the latest Univest figures. The data confirms the repeated-high price pattern, but it does not establish why the stock has continued to set new highs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_SMSPHARMA_valued_compared_with_its_industry\"><\/span><strong>How is SMSPHARMA valued compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SMS Pharmaceuticals Ltd. trades at a P\/E of 42.46 and a P\/B of 5.39. That places it above the industry median on both counts, so valuation is an important part of the stock\u2019s current story.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_profitability_ratios_show\"><\/span><strong>What do the profitability ratios show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SMS Pharmaceuticals Ltd. reports ROE of 11.91% and ROCE of 12.55%. ROE is close to the industry median, while ROCE is slightly below the industry median, so the return profile is mixed.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_the_stock_being_watched_now\"><\/span><strong>Why is the stock being watched now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock is being watched because it has set back-to-back 52-week highs and remains in the, Stocks Hitting 52 Week Highs, conversation. Investors are also comparing its valuation, returns and peer positioning.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next\"><\/span><strong>What should investors monitor next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should monitor the next price print, whether the repeated-high pattern continues, and how the stock is valued versus peers. The latest share price, market capitalisation and industry multiples are the key reference points now.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_SMS_Pharmaceuticals_Ltd_SMSPHARMA_Share_Price_on_Univest\"><\/span><strong>Track SMS Pharmaceuticals Ltd. (SMSPHARMA) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/smspharma\/sms-pharmaceuticals-ltd-share-price-today\">SMS Pharmaceuticals Ltd. (SMSPHARMA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What does SMS Pharmaceuticals Ltd. 52 Week High Streak mean?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It means SMS Pharmaceuticals Ltd. has set a fresh 52-week high on consecutive sessions. In this case, the streak is for a second straight session, which makes the one-year high pattern more notable than a single-day breakout.\"}},{\"@type\":\"Question\",\"name\":\"How many sessions has SMSPHARMA made a fresh 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SMS Pharmaceuticals Ltd. has made a fresh 52-week high for two consecutive sessions. The latest streak label is second straight session, and the cumulative move across that run is 6.48%.\"}},{\"@type\":\"Question\",\"name\":\"What is the latest 52-week high for SMS Pharmaceuticals Ltd.?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest 52-week high for SMS Pharmaceuticals Ltd. is Rs 482.45. The stock touched that level during the current streak, which is why the move is being tracked as a repeated one-year high event.\"}},{\"@type\":\"Question\",\"name\":\"Is a company-specific catalyst confirmed for the streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No company-specific catalyst is confirmed by the latest Univest figures. The data confirms the repeated-high price pattern, but it does not establish why the stock has continued to set new highs.\"}},{\"@type\":\"Question\",\"name\":\"How is SMSPHARMA valued compared with its industry?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SMS Pharmaceuticals Ltd. trades at a P\/E of 42.46 and a P\/B of 5.39. That places it above the industry median on both counts, so valuation is an important part of the stock\u2019s current story.\"}},{\"@type\":\"Question\",\"name\":\"What do the profitability ratios show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SMS Pharmaceuticals Ltd. reports ROE of 11.91% and ROCE of 12.55%. ROE is close to the industry median, while ROCE is slightly below the industry median, so the return profile is mixed.\"}},{\"@type\":\"Question\",\"name\":\"Why is the stock being watched now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock is being watched because it has set back-to-back 52-week highs and remains in the, Stocks Hitting 52 Week Highs, conversation. Investors are also comparing its valuation, returns and peer positioning.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor next?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should monitor the next price print, whether the repeated-high pattern continues, and how the stock is valued versus peers. The latest share price, market capitalisation and industry multiples are the key reference points now.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SMS Pharmaceuticals Ltd. Share Price hits a new 52-week high at Rs 446.3, marking a -3.88% rise today. Market cap stands at Rs 4,348.26 crore.<\/p>\n","protected":false},"author":29,"featured_media":245388,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-245389","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["245388"],"rank_math_title":["SMSPHARMA Consecutive Highs: Fundamental And Sector View"],"rank_math_description":["SMS Pharmaceuticals Ltd. has set a fresh 52-week high for a second straight session, with valuation, sector and peer context in focus."],"rank_math_focus_keyword":["SMS Pharmaceuticals Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/SMS_Pharmaceuticals_Ltd_SMSPHARMA_52_Week_High_Streak_Second_Straight_Session_Holds_Focus_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=245389"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245389\/revisions"}],"predecessor-version":[{"id":245390,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245389\/revisions\/245390"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/245388"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=245389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=245389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=245389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}